Clinical TrialsSearch results
Number of results: 857
Other
- Phase I/II trial of hepatic arterial infusion of FMP therapy for advanced hepatocellular carcinoma
- advanced hepatocellular carcinoma
- Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital
- 2006-09-12
Other
- Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma (JCOG0604)
- esophageal neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2007-05-08
Other
- Phase I/II study of Intraoperative radiation therapy in early breast cancer
- early breast cancer
- Nagoya University school of Medicine
- 2008-10-01
Other
- Phase I/II study of intermittent erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer
- Non-small cell lung cancer
- West Japan Oncology Group
- 2009-03-17
Other
- Phase I/II study of hepatic arterial infusion chemotherapy of gemcitabine for unresectable cholangiocarcinoma (JIVROSG-0301)
- Unresectable cholangiocarcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Phase I/II study of docetaxel, CDDP and 5-FU therapy in patients with unresectable or recurrent esophageal cancer (JCOG 0807)
- esophageal neoplasm
- Japan Clinical Oncology Group (JCOG)
- 2009-02-27
Other
- Phase I/II study of adoptive immunotherapy using predetermined minor histocompatibility antigen-specific cytotoxic T cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantation.
- 1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CML
- Aichi Cancer Center
- 2005-09-12
Other
- Phase I/II study of adoptive immunotherapy using cytotoxic T cells specific for minor histocompatibility antigen restricted to hematopoietic cells for patients with high-risk leukemia that relapsed following allogeneic hematopoietic stem cell transplantation
- 1) RAEB, CMML 2) AML or ALL in induction failure or beyond first remission 3) Ph/p190-positive ALL at any stage 4) imatinib-resistant CML
- Aichi Cancer Center
- 2005-09-12
Other
- Phase I study of weekly amrubicin in patients with refractory or relapsed lung cancer
- lung cancer
- Central Japan Lung Study Group
- 2008-04-20
Other
- Phase I study of non-myeloablative conditioning regimen of Fludarabine/melphalan for hematopoietic stemcell transplantation from HLA matched sibling donors in patient with multiple myeloma that refractory or relapsed for autologous stem cell transplantation (C-SHOT0403)
- Multiple myeloma that refractory or relapsed for autologous stem cell transplantation
- Nagoya BMT Group
- 2005-09-12